A. Terabe

Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.

Tsutomu Suzuki, T. Fujita, A. Yamamoto, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon

Tsutomu Suzuki, C. Tada, A. Yamamoto, 1997 .

Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.

T. Maruyama, C. Tada, A. Yamamoto, 1996, Journal of pharmaceutical sciences.

Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.

T. Fujita, A. Yamamoto, S. Muranishi, 1999, Life sciences.

Reaction between chitosan and cellulose on biodegradable composite film formation

A. Terabe, J. Hosokawa, M. Nishiyama, 1991 .

Validation of a Pharmacokinetic Model of Colon‐specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5‐Aminosalicylic Acid on 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats

T. Fujita, A. Yamamoto, S. Muranishi, 1999, The Journal of pharmacy and pharmacology.